Target type: biologicalprocess
The chemical reactions and pathways resulting in the breakdown of glycosides, compounds in which a glycosyl group is substituted into a hydroxyl, thiol or selenol group in another compound. [GOC:go_curators]
Glycoside catabolic processes encompass the breakdown of glycosides, a diverse class of molecules composed of a sugar moiety (glycone) linked to a non-sugar moiety (aglycone) via a glycosidic bond. These processes are essential for various biological functions, including nutrient acquisition, detoxification, and signal transduction.
The breakdown of glycosides typically occurs in two main steps:
1. **Glycosidic Bond Cleavage:** The glycosidic bond linking the glycone and aglycone is hydrolyzed, releasing the sugar and aglycone. This step is catalyzed by glycosidases, a family of enzymes with diverse substrate specificities. The mechanism of glycosidic bond cleavage can involve acid hydrolysis, where protons facilitate the bond breaking, or enzymatic hydrolysis, where glycosidases utilize a specific catalytic mechanism.
2. **Further Metabolism of Released Components:** The released sugar moiety can be further metabolized through glycolysis or other metabolic pathways. The aglycone, depending on its chemical structure, can undergo a variety of metabolic fates, including further breakdown, detoxification, or modification for biological activity.
**Examples of Glycoside Catabolic Processes:**
- **Lactose Metabolism:** The breakdown of lactose, a disaccharide, is catalyzed by lactase, which cleaves the glycosidic bond between glucose and galactose.
- **Starch Digestion:** Amylase, a digestive enzyme, hydrolyzes starch into smaller oligosaccharides and ultimately glucose.
- **Detoxification of Xenobiotics:** Some glycosides, such as plant toxins, are detoxified by hydrolysis, followed by further metabolism and excretion.
- **Signal Transduction:** Glycosides, such as steroid hormones, play a crucial role in cell signaling. Their breakdown can activate or terminate downstream signaling pathways.
**Importance of Glycoside Catabolic Processes:**
- **Nutrient Acquisition:** Breakdown of glycosides, such as starch and lactose, provides essential sugars for energy production and biosynthesis.
- **Detoxification:** Cleavage of glycosidic bonds can eliminate harmful glycosides from the body.
- **Cell Signaling:** Glycoside catabolism plays a role in regulating various cellular processes, including growth, differentiation, and metabolism.
Overall, glycoside catabolic processes are essential for maintaining cellular homeostasis, acquiring nutrients, and responding to environmental stimuli. These processes involve a complex interplay of enzymes, substrates, and metabolic pathways, ensuring the efficient breakdown and utilization of glycosides in biological systems.'
"
Protein | Definition | Taxonomy |
---|---|---|
Alpha-galactosidase A | An alpha-galactosidase A that is encoded in the genome of human. [PRO:DNx, UniProtKB:P06280] | Homo sapiens (human) |
Non-lysosomal glucosylceramidase | A non-lysosomal glucosylceramidase that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9HCG7] | Homo sapiens (human) |
Cytosolic beta-glucosidase | A cytosolic beta-glucosidase that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9H227] | Homo sapiens (human) |
Tissue alpha-L-fucosidase | A tissue alpha-L-fucosidase that is encoded in the genome of human. [PRO:DNx, UniProtKB:P04066] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
1-deoxynojirimycin | 1-deoxy-nojirimycin: structure in first source duvoglustat : An optically active form of 2-(hydroxymethyl)piperidine-3,4,5-triol having 2R,3R,4R,5S-configuration. | 2-(hydroxymethyl)piperidine-3,4,5-triol; piperidine alkaloid | anti-HIV agent; anti-obesity agent; bacterial metabolite; EC 3.2.1.20 (alpha-glucosidase) inhibitor; hepatoprotective agent; hypoglycemic agent; plant metabolite |
miglustat | miglustat : A hydroxypiperidine that is deoxynojirimycin in which the amino hydrogen is replaced by a butyl group. miglustat: a glucosylceramide synthase inhibitor | piperidines; tertiary amino compound | anti-HIV agent; EC 2.4.1.80 (ceramide glucosyltransferase) inhibitor |
castanospermine | castanospermine : A tetrahydroxyindolizidine alkaloid that consists of octahydroindolizine having four hydroxy substituents located at positions 1, 6, 7 and 8 (the 1S,6S,7R,8R,8aR-diastereomer). castanospermine: indolizidine alkaloid from seeds of Australian legume, Castanospermum australe | indolizidine alkaloid | anti-HIV-1 agent; anti-inflammatory agent; EC 3.2.1.* (glycosidase) inhibitor; metabolite |
besipirdine | besipirdine: structure given in first source; a non-receptor-dependent cholinomimetic agent with noradrenergic activity with potential use for treating Alzheimer's disease | ||
1-deoxymannojirimycin | |||
deoxyfuconojirimycin | deoxyfuconojirimycin : A hydroxypiperidine in which the three hydroxy substituents are located at positions 3, 4 and 5 together with an additional methyl substituent at position 2. deoxyfuconojirimycin: structure given in first source | hydroxypiperidine; triol | fungal metabolite |
2,5-dihydroxymethyl-3,4-dihydroxypyrrolidine | 2,5-dihydroxymethyl-3,4-dihydroxypyrrolidine: structure given in first source | dihydroxypyrrolidine | |
migalastat | migalastat: a potent inhibitor of glycolipid biosynthesis | piperidines | |
2,5-dideoxy-2,5-imino-d-glucitol | 2,5-dideoxy-2,5-imino-D-glucitol: structure in first source | ||
validamine | validamine : An amino cyclitol consisting of 1D-chiro-inositol lacking the 6-hydroxy group and having those at positions 1 and 5 replaced by amino and hydroxymethyl groups respectively. validamine: RN given from CA Index Guide; RN not in Chemline 11/84; structure given in first source | amino cyclitol | |
isofagomine | piperidines | ||
1,4-dideoxy-1,4-imino-d-arabinitol | |||
n-nonyl-1-deoxynojirimycin | N-nonyldeoxynojirimycin : A hydroxypiperidine that is deoxynojirimycin (duvoglustat) in which the amino hydrogen is replaced by a nonyl group. | hydroxypiperidine; tertiary amino compound | antiviral agent; EC 3.2.1.20 (alpha-glucosidase) inhibitor; EC 3.2.1.45 (glucosylceramidase) inhibitor |
n-(5-adamantane-1-yl-methoxy-pentyl)deoxynojirimycin | |||
ogt2378 | sinbaglustat: an antineopl agent; structure in first source | ||
l-altro-1-deoxynojirimycin | L-altro-1-deoxynojirimycin: structure in first source |